Back
Cyclo Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
43
CYTH
Cyclo Therapeutics
Last Price:
1.53
Seasonality Move:
4.15%
Sell
25
NBY
NovaBay Pharmaceuticals
Last Price:
0.09
Seasonality Move:
-8.08%
Sell
43
Cyclo Therapeutics (CYTH)
is a Sell
Is Cyclo Therapeutics a Buy, Sell or Hold?
- The current Cyclo Therapeutics [CYTH] share price is $1.47. The Score for CYTH is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- CYTH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.09. The Score for NBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTH Stock Price Chart
What is Cyclo Therapeutics's stock price today?
-
The Cyclo Therapeutics share price today is $1.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTH is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.09
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
CYTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 57.76 | Buy |
| Chaikin Money Flow: | -3789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.24 - 1.42) | Buy |
| Bollinger Bands (100): | (1.35 - 1.75) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.92 | Sell |
| Chaikin Money Flow: | 519106 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Sell |
| Bollinger Bands (100): | (0.1 - 0.2) | Sell |
CYTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.36 | Buy |
| 20-day SMA: | 1.32 | Buy |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 1.46 | Buy |
| 8-day EMA: | 1.39 | Buy |
| 20-day EMA: | 1.36 | Buy |
| 50-day EMA: | 1.43 | Buy |
| 200-day EMA: | 1.5 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Buy |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.12 | Sell |
| 200-day SMA: | 0.32 | Sell |
| 8-day EMA: | 0.08 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.55 | Sell |
Cyclo Therapeutics Earnings Growth & CYTH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Cyclo Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||